Latest autoimmune diseases Stories
One human antibody known as BI 655066 is a promising candidate to be used to target the inflammation-causing protein, interleukin-23.
John Galgiani, M.D. and Chaim Putterman, M.D.
DALLAS, March 10, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Colitis - Pipeline Review, H1 2015" therapeutic market research report of 74 pages with latest updates,
In a screen of more than 100,000 potential drugs, only one, harmine, drove human insulin-producing beta cells to multiply, according to a new study led by researchers at the Icahn School of Medicine
Topical BioMedics—the formulators of Topricin—is helping doctors and patients have more options and better tools to create improved treatment protocols for many types of arthritis and other
DOWNERS GROVE, Ill., March 5, 2015 /PRNewswire-USNewswire/ -- The American Society for Gastrointestinal Endoscopy (ASGE) and the American Gastroenterological Association (AGA) have issued updated
NEW YORK, March 5, 2015 /PRNewswire-USNewswire/ -- Known collectively as inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis can be extremely isolating.
- Tradipitant and placebo both showed significant improvements from baseline WASHINGTON, March 4, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc.
RnRMarketResearch.com adds “Alopecia – Pipeline Review, H1 2015” report to its store.
Progress May Also Hold Promise For Multiple Sclerosis, Type 1 Diabetes and Other Autoimmune Conditions LOS ANGELES, March 2, 2015 /PRNewswire/ -- Encouraged by new, targeted smart-drug
- One who brings meat to the table; hence, in some countries, the official title of the grand master or steward of the king's or a nobleman's household.